AI in Medical Writing Market Size

AI in Medical Writing Market size was over USD 859.9 million in 2024 and is estimated to reach USD 3.84 billion by the end of 2037, expanding at a CAGR of 13.3% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of AI in medical writing is evaluated at USD 974.2 million. The increasing complexity of healthcare data, the need for faster drug approvals, and the rise in clinical trials are key factors fueling the adoption of AI in medical writing. Technologies, such as NLP, and machine learning are helping reduce human error, improve accuracy, and streamline workflows, particularly in the pharmaceutical and healthcare sectors.

Moreover, regulatory authorities in various regions are starting to accept AI-generated documents, further accelerating the AI in medical writing market growth. In the upcoming years, AI is expected to advance further in automating not just routine writing tasks but also predictive analytics in clinical research. In June 2023, Amazon Web Services, Inc. announced a new HIPAA-eligible service, AWS HealthScribe with generative AI capabilities for natural language processing solutions. Such activities are projected to further boost the artificial intelligence (AI) in medical writing market expansion globally.